IPXHF(IPXHF)
IPXHF
No analyst ratings available
No analyst price targets available for IPXHF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $2.22T | $2.29T | $2.27T | $2.26T | $2.31T |
| Low | $2.00T | $1.96T | $1.99T | $1.98T | $2.03T |
| High | $2.49T | $2.51T | $2.52T | $2.50T | $2.56T |
| EBITDA Avg | $1.01T | $1.00T | $980.26B | $926.36B | $995.08B |
| Low | $907.03B | $896.91B | $876.34B | $829.17B | $885.49B |
| High | $1.10T | $1.09T | $1.07T | $1.01T | $1.09T |
| EBIT Avg | $682.98B | $692.16B | $685.16B | $643.29B | $720.49B |
| Low | $579.41B | $587.12B | $581.24B | $546.10B | $610.90B |
| High | $773.39B | $783.86B | $775.87B | $728.14B | $816.16B |
| Net Income Avg | $509.23B | $516.48B | $510.95B | $477.88B | $538.86B |
| Low | $427.41B | $433.50B | $428.86B | $401.10B | $452.29B |
| High | $580.65B | $588.92B | $582.61B | $544.90B | $614.44B |
| EPS Avg | $427.42 | $433.50 | $428.86 | $401.10 | $452.29 |
| Low | $358.74 | $363.85 | $359.96 | $336.66 | $379.62 |
| High | $487.36 | $494.30 | $489.01 | $457.36 | $515.73 |
| Analysts (Rev / EPS) | 9 / 1 | 10 / 1 | 4 / 1 | 5 / 1 | 5 / 1 |
| Metric | Q3 2026 | Q4 2026 |
|---|---|---|
| Revenue Avg | $533.00B | $593.86B |
| Low | $510.67B | $531.43B |
| High | $555.32B | $656.28B |
| EBITDA Avg | $274.37B | $297.67B |
| Low | $260.76B | $281.58B |
| High | $287.98B | $313.76B |
| EBIT Avg | $172.24B | $197.55B |
| Low | $158.62B | $181.46B |
| High | $185.85B | $213.64B |
| Net Income Avg | $109.99B | $129.99B |
| Low | $99.24B | $117.28B |
| High | $120.75B | $142.70B |
| EPS Avg | $94.68 | $111.90 |
| Low | $85.42 | $100.95 |
| High | $103.94 | $122.84 |
| Analysts (Rev / EPS) | 2 / 1 | 2 / 1 |